Tomita Y, Takeda A, Matsunaga J, Okinaga S, Shibahara S, Tagami H
Department of Dermatology, Thoku University School of Medicine, Sendai, Japan.
Pigment Cell Res. 1992;Suppl 2:96-100. doi: 10.1111/j.1600-0749.1990.tb00356.x.
We have identified two different mutations in the tyrosinase genes of Japanese patients with tyrosinase-negative oculocutaneous albinism (OCA). One is a single base insertion in the exon 2 of the tyrosinase gene that shifts the reading frame and introduces a premature termination codon (TGA) after the amino acid residue 298 (codon 316). The other is a G to A transition at residue 312, leading to a single amino acid substitution, arginine at position 59 (codon 77) to glutamine. The promoter activity of the patients' tyrosinase genes was evaluated in the cell-free transcription system prepared from pigmented melanoma cells, indicating that the patients' genes were accurately transcribed in vitro. It is therefore conceivable that the tyrosinase gene is expressed in their melanocytes. Furthermore, transient expression of the mutated genes indicates that the truncated tyrosinase or the tyrosinase containing glutamine 59 is unable to form melanin in melanocytes. We therefore propose that these mutations in the tyrosinase genes lead to a phenotype of tyrosinase-negative OCA.
我们在日本酪氨酸酶阴性眼皮肤白化病(OCA)患者的酪氨酸酶基因中鉴定出两种不同的突变。一种是酪氨酸酶基因外显子2中的单碱基插入,它改变了阅读框,并在氨基酸残基298(密码子316)之后引入了一个提前终止密码子(TGA)。另一种是第312位残基处的G到A转换,导致单个氨基酸取代,即第59位(密码子77)的精氨酸被谷氨酰胺取代。在从色素性黑色素瘤细胞制备的无细胞转录系统中评估了患者酪氨酸酶基因的启动子活性,表明患者的基因在体外被准确转录。因此可以推测酪氨酸酶基因在他们的黑素细胞中表达。此外,突变基因的瞬时表达表明,截短的酪氨酸酶或含有谷氨酰胺59的酪氨酸酶在黑素细胞中无法形成黑色素。因此,我们认为酪氨酸酶基因中的这些突变导致了酪氨酸酶阴性OCA的表型。